Noninvasive Tests for Lupus Nephritis Activity
Renal Arterial Resistive Index as a Noninvasive Biomarker of Disease Activity in Lupus Nephritis Patients
Recruiting
Observational Study
Lupus Nephritis
No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
No Study Drug
Researchers observe your health over time — no experimental treatment is given.
At a Glance
- Age
- 18 – 50
- Sex
- Any
- Study type
- Observational
- Participants needed
- 55 (estimated)
- Sponsor
- Sohag University · Other
Who this trial is looking for
This trial is looking for adults with lupus nephritis to study a test that can help measure disease activity. Participants will need to answer questions and provide consent.
Are You a Good Fit for This Trial?
You may be able to join if
- I am 18 years or older.
- I have been diagnosed with systemic lupus erythematosus.
- I can answer questions.
- I am willing to give written informed consent.
You may not be able to join if
- I have another autoimmune disease.
- I have diabetes.
- I have high blood pressure.
- I have heart failure.
- I have liver disease.
- I have chronic kidney failure.
- I have renal artery stenosis.
- I am unable to give written informed consent.
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
Systemic Lupus Erthymatosous (SLE) is achronic inflammatory multi system auto immue disease characterized by pathogenic auto anti bodies production against nuclear structures (Bolouri et al.,2022), SLE affecting mainly woemn of childbearing age and is chracterized by unpredictable flares and remissions , disease variety varied from mild episode disorder to arpidly progressive life -threatening ill…
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Aged ≥18 years.
* SLE patients fulfilling the SLE International Collaborating Clinics (SLICC) classification criteria and matched controls.
* Patients cooperative and can answer questions.
* Patients who are able and willing to give written informed consent.
Exclusion Criteri…
Contacts
Esam M Abualfadl, professor
CONTACT